Sung Min Bae

This inventor holds 31 USPTO granted patents and 7 published patent applications, plus 12 CIPO patents and 18 EPO patents. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd., Hanmi Holdings Co., Ltd.. Active years: 2003-2025.

USPTO Granted Patents = 31 (Patent Applications = 7)

% Patents Active = 77.4

CIPO Patents = 12 (Patent Applications = 3)

EPO Patents = 18 (Patent Applications = 10)

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 160(Granted Patents)

Location History:

Taegu, KR (2003)
Seocho-gu, KR (2010)
Seoul, KR (2012 - 2018)
Seongnam-si, KR (2014 - 2021)
Sengnam-si, KR (2021)
Hwaseong-si, KR (2021 - 2023)

Company Filing History:

17 out of 148

Hanmi Pharm. Co., Ltd.

patents

11 out of 63

Hanmi Science Co., Ltd.

patents

1 out of 12

Hanmi Holdings Co., Ltd.

patents

4. 1 out of 316

Korea Institute of Industrial Technology

patents

5. 1 out of 834,307

Other

patents

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Immunoglobulin Fragments

Protein Conjugates

Long-Acting Hormones

Polyethylene Glycol Derivatives

Biologically Active Polypeptides

Liquid Formulations

Insulin Conjugates

Oxyntomodulin Derivatives

Stability Improvement

Orthodontic Treatment Devices

Erythropoietin Conjugates

G-CSF Conjugates

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12508298 - PROTEIN COMPLEX BY USE OF A SPECIFIC SITE OF AN IMMUNOGLOBULIN FRAGMENT FOR LINKAGE (2025-12-30),

2. 12274750 - Lyophilized formulation of long-acting human growth hormone immunoglobulin conjugate (2025-04-14),

3. 12139455 - Polyethylene glycol derivative and use thereof (2024-11-12),

4. 11603346 - Polyethylene glycol derivative and use thereof (2023-03-14),

5. 11389508 - Protein complex by use of a specific site of an immunoglobulin fragment for linkage (2022-07-19),

6. 11207383 - Protein complex by use of a specific site of an immunoglobulin fragment for linkage (2021-12-28),

7. 11168109 - Process for preparation of physiologically active polypeptide complex (2021-11-09),

8. 11135271 - Glucagon derivatives with improved stability (2021-10-05),

9. 11071785 - Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin Fc region (2021-07-27),

10. 10987425 - Liquid formulation of long-acting human growth hormone immunoglobulin conjugate (2021-04-27),

11. 10987424 - Liquid formulation of long-acting insulin conjugate (2021-04-27),

12. 10744187 - Insulin conjugate using an immunoglobulin fragment (2020-08-18),

13. 10487128 - Conjugate of biologically active polypeptide monomer and immunoglobulin Fc fragment with reduced receptor-mediated clearance, and the method for preparing the same (2019-11-26),

14. 10441665 - Liquid formulation of long acting insulinotropic peptide conjugate (2019-10-15),

15. 10279041 - Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment (2019-05-07),

Title: Innovations and Contributions of Sung Min Bae

Introduction

Sung Min Bae, based in Seongnam-si, South Korea, is a prolific inventor with an impressive portfolio of 28 patents. His work primarily focuses on the development and application of polyethylene glycol derivatives, which have significant implications in various fields.

Latest Patents

Among his latest innovations, Bae has developed a patent titled "Polyethylene glycol derivative and use thereof." This patent discloses polyethylene glycol derivatives of a specific formula, alongside methods for their production and applications. Another noteworthy patent from him is also titled "Polyethylene glycol derivative and use thereof," which details further advancements in the field of polyethylene glycol derivatives and their uses.

Career Highlights

Sung Min Bae has achieved remarkable milestones throughout his career. He has collaborated with leading pharmaceutical firms such as Hanmi Pharm. Co., Ltd. and Hanmi Science Co., Ltd. His contributions in these organizations have significantly influenced the pharmaceutical landscape, particularly in the realm of innovative drug delivery systems.

Collaborations

Bae has also worked alongside notable colleagues like Se Chang Kwon and Dae Jin Kim. Their collaboration has undoubtedly fostered an environment of innovation, leading to the successful development of several cutting-edge technologies.

Conclusion

Sung Min Bae's remarkable innovations and dedicated research efforts have not only led to a substantial number of patents but have also paved the way for advancements in the field of polyethylene glycol derivatives. His works are a testament to his commitment to innovation and excellence in the scientific community.